scholarly journals A Preliminary Analysis Of Health Care Resource Utilization Of Paliperidone Palmitate In The Treatment Of Schizophrenia In The Public Health Care Sector Of Hong Kong

2016 ◽  
Vol 19 (3) ◽  
pp. A187
Author(s):  
WY Choon
Keyword(s):  
Public Health ◽  
Health Care ◽  
Hong Kong ◽  
Resource Utilization ◽  
Preliminary Analysis ◽  
Health Care Resource ◽  
Public Health Care ◽  
Paliperidone Palmitate ◽  
The Public ◽  
Health Care Resource Utilization

scholarly journals Predicting High Health Care Resource Utilization in a Single-payer Public Health Care System

Medical Care ◽  
2018 ◽  
Vol 56 (10) ◽  
pp. e61-e69 ◽  
Author(s):  
Laura C. Rosella ◽  
Kathy Kornas ◽  
Zhan Yao ◽  
Douglas G. Manuel ◽  
Catherine Bornbaum ◽  
...  
Keyword(s):  
Public Health ◽  
Health Care ◽  
Health Care System ◽  
Resource Utilization ◽  
Health Care Resource ◽  
Public Health Care ◽  
Public Health Care System ◽  
Health Care Resource Utilization ◽  
Single Payer ◽  
Care System

scholarly journals Health Care Resource Utilization and Costs Associated with Transitioning to 3-month Paliperidone Palmitate Among US Veterans

2018 ◽  
Vol 40 (9) ◽  
pp. 1496-1508 ◽  
Author(s):  
Maral DerSarkissian ◽  
Patrick Lefebvre ◽  
Kruti Joshi ◽  
Brianne Brown ◽  
Marie-Hélène Lafeuille ◽  
...  
Keyword(s):  
Health Care ◽  
Resource Utilization ◽  
Health Care Resource ◽  
Paliperidone Palmitate ◽  
Health Care Resource Utilization ◽  
Us Veterans

10: Adults with Overactive Bladder have Significant Health Care Resource Utilization- Evidence from a Large Medicaid Population

2006 ◽  
Vol 175 (4S) ◽  
pp. 4-4
Author(s):  
Gurkirpal Singh ◽  
Smriti Malla ◽  
Huijian Wang ◽  
Harcharan Gill ◽  
Kristijian H. Kahler ◽  
...  
Keyword(s):  
Health Care ◽  
Overactive Bladder ◽  
Resource Utilization ◽  
Health Care Resource ◽  
Health Care Resource Utilization ◽  
Medicaid Population ◽  
Significant Health

scholarly journals The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States

2020 ◽  
Vol 16 ◽  
pp. 174550652096589
Author(s):  
Stephanie J Estes ◽  
Ahmed M Soliman ◽  
Marko Zivkovic ◽  
Divyan Chopra ◽  
Xuelian Zhu
Keyword(s):  
Health Care ◽  
High Risk ◽  
Resource Utilization ◽  
Health Care Resource ◽  
Low Risk ◽  
Opioid Use ◽  
Health Care Resource Utilization ◽  
Outpatient Visits ◽  
Chronic Opioid Use ◽  
Opioid Users

Objectives: Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid use. Methods: A retrospective analysis of IBM MarketScan® Commercial Claims data from 2009 to 2018 was performed for females aged 18 to 49 with newly diagnosed endometriosis (International Classification of Diseases, Ninth Edition code: 617.xx; International Classification of Diseases, Tenth Edition code: N80.xx). Two sub-cohorts were identified: high-risk (⩾1 day with ⩾90 morphine milligram equivalents per day or ⩾1-day concomitant benzodiazepine use) or chronic opioid utilization (⩾90-day supply prescribed or ⩾10 opioid prescriptions). High-risk or chronic utilization was evaluated during the 12-month assessment period after the index date. Index date was the first opioid prescription within 12 months following endometriosis diagnosis. All outcomes were assessed over 12-month post-assessment period while adjusting for demographic and clinical characteristics. Results: Out of 61,019 patients identified, 18,239 had high-risk opioid use and 5001 chronic opioid use. Health care resource utilization drivers were outpatient visits and pharmacy fills, which were higher among high-risk versus low-risk patients (outpatient visits: 17.49 vs 15.51; pharmacy fills: 19.58 vs 16.88, p < 0.0001). Chronic opioid users had a higher number of outpatient visits (19.53 vs 15.00, p < 0.0001) and pharmacy fills (23.18 vs 16.43, p < 0.0001) compared to non-chronic opioid users. High-risk opioid users had significantly higher all-cause health care costs compared to low-risk opioid users (US$16,377 vs US$13,153; p < 0.0001). Chronic opioid users also had significantly higher all-cause health care costs compared to non-chronic opioid users (US$20,930 vs US$12,272; p < 0.0001). Similar patterns were observed among endometriosis-related HCRU, except pharmacy fills among high-risk and chronic sub-cohorts. Conclusion: This analysis demonstrates significantly higher all-cause and endometriosis-related health care resource utilization and total costs for high-risk opioid users compared to low-risk opioid users among newly diagnosed endometriosis patients over 1 year. Similar trends were observed for comparing chronic opioid users with non-chronic opioid users, except for endometriosis-related pharmacy fills and associated costs.

Sign in / Sign up

Export Citation Format

Share Document